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Abstract. A modification of "reverse chromosome painting" 
was carried out using genomic DNA from tumor cells as a 
complex probe for chromosomal in situ suppression hy- 
bridization to normal metaphase chromsome spreads. Ampli- 
fied DNA sequences contained in such probes showed spe- 
cific signals, revealing the normal chromosome positions 
from which these sequences were d rived, As a model sys- 
tem, genomic DNAs were analyzed from three tumor cell 
lines with amplification units including the proto-oncogene 
c-myc. The smallest amplification unit was about 90 kb and 
was present in 16-24 copies; the largest unit was bigger than 
600 kb and was present in 16-32 copies. Specific signals that 
co-localized with a differently labeled c-myc probe on chro- 
mosome band 8q24 were obtained with genomic DNA from 
each cell line. In further experiments, genomic DNA derived 
from primary tumor material was used in the case of a male 
patient with glioblastoma multiforme (GBM). Southern blot 
analysis using an epidermal growth factor receptor gene 
(EGFR) probe that maps to 7p13 indicated the amplification 
of sequences from this gene. Using reverse chromosome 
painting, signals were found both on band 7p13 and bands 
12q13-q15. Notably, the signal on 12q13-q15 was consis- 
tently stronger. The weaker 7p13 signal showed co-localiza- 
tion with the major signal of the differently labeled EGFR 
probe. A minor signal of this probe was seen on 12q13, sug- 
gesting cross-hybridization to ERB3 sequences homologous 
to EGFR. The results indicate co-amplification f sequences 
from bands 12q13 q15, in addition to sequences from band 
7p 13. Several oncogenes map to 12q 13-q 15 providing candi- 
date genes for a tumor-associated proto-oncogene amplifica- 
tion. Although the nature of the amplified sequences n eds to 
be clarified, this experiment demonstrates the potential of re- 
verse chromosome painting with genomic tumor DNA for 
rapidly mapping the normal chromosomal localization of the 
DNA from which the amplified sequences were d rived. In 
addition, a weaker staining of chromosomes 10 and X was 
consistently observed indicating that these chromosomes 
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were present in only one copy in the GBM genome. This 
rapid approach can be used to analyze cases where no 
metaphase spreads from the tumor material are available. It 
does not require any preknowledge of amplified sequences 
and can be applied to screen large numbers of tumors. 
Introduction 
Following the discovery of amplified genes in cultured cells 
selected for drug resistance or responding to environmental 
stress, specific amplification of genomic sequences has also 
been discovered in numerous tumors. Amplified sequences 
in tumor genomes frequently contain specific proto-onco- 
genes (Atitalo and Schwab 1986). Cytogenetic analysis of tu- 
mor cell cultures has revealed that amplified DNA can be 
present either in double minute chromosomes (DMINs), 
small acentric hromosome-like structures that are frequently 
paired, or in homogeneously staining chromosomal regions 
(HSRs), visible with intermediate intensity using conven- 
tional banding techniques. However, our knowledge of the 
complexities of amplified sequences in primary tumors is 
still very limited. 
Since the chromosomal origin of sequences in DMINs and 
HSRs cannot be determined by the analysis of banded chro- 
mosomes, assessment of the amplified genes is usually car- 
ried out by in situ and Southern blot hybridization of large 
numbers of proto-oncogene probes. However, these analyses 
rely entirely on the availability of suitable probe panels. In 
addition, co-amplified regions might often not be identified. 
In the case of in situ hybridization, high quality metaphase 
spreads are required from the cells to be analyzed. However, 
in many cases (as in certain hematological nd many solid tu- 
mors) such metaphases cannot be obtained. The possibilities 
of carrying out such an analysis on interphase nuclei (Bar- 
Am et al. 1992) remain restricted. 
In the present study, analternative approach is applied to 
analyze unknown amplified regions of a genome (Kallio- 
niemi et al. 1992). This approach provides a new example of 
a strategy termed "reverse chromosome painting" (Carter et 
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Fig. 1. Reverse chromosome painting. Schematic illustration of the re- 
verse chromosome painting approach and several of it  applications. La- 
beled DNA from various sources is hybridized to metaphase chromo- 
some spreads from normal cells. The lower part of the scheme illustrates 
the results for four different DNA sources. Left olumn List of the DNA 
sources; right column partial karyotypes of the hybridized normal chro- 
mosome complements with the resulting hybridization signals. Unla- 
beled chromosomes or chromosomal regions a  sh wn in white and 
strongly labeled regions are shown in black. Total genomic DNA as a 
probe (for example, tumor cell DNA from the sa e species), results in 
general chromosomal staining shown in grey. A staining stronger than 
general chromosomal staining due to over-representation of quences 
is indicated in black, and staining weaker than genera/ chromosomal 
staining due to under-representation of sequences is dotted. HSR Homo- 
geneously staining chromosomal region; DMIN double minute 
al. 1992). The principles of this procedure are outlined 
schematically in Fig. 1. The first applications of this ap- 
proach were presented in studies investigating the chromoso- 
mal content of interspecies hybrid cells (Boyle et al. 1990; 
Kievits et al. 1990). The whole genomic DNA of a hybrid 
cell line was used as a probe for chromosomal in situ sup- 
pression (CISS) hybridization on metaphase spreads from 
normal cells of a species of interest. By this approach, all 
chromosomes and chromosomal segments of this species 
present in the hybrid cell were easily identified. Further im- 
provements of this approach were achieved by species-spe- 
cific polymerase chain reaction (PCR) amplification products 
from such hybrid lines (Lengauer et al. 1990; Lichter et al. 
1990). Reverse chromosome painting has also been success- 
fully used to identify marker chromosomes in disease cases. 
After flow sorting of a marker chromosome, its DNA was 
amplified and used as a probe for CISS hybridization to nor- 
mal human chromosomes (Telenius et al. 1992). This allows 
the rapid identification of the origin(s) of the marker chromo- 
some. Reverse chromosome painting also allows a compre- 
hensive analysis for identifying imbalanced chromosomal 
material of entire genomes when using the whole genomic 
DNA as a probe (see also Kallioniemi et al. 1992 and the ac- 
companying paper by du Manoir et al. 1993). 
In the present study, we demonstrate he application of re- 
verse chromosome painting to identify the chromosomal ori- 
gin of amplified regions using genomic tumor cell DNA as a 
probe. First, three cell lines were analyzed with amplification 
units containing the proto-oncogene c-myc. Secondly, a pri- 
mary glioblastoma multiforme (GBM) tumor was investi- 
gated, in which Southern blot analysis suggested multiple 
copies of the epidermal growth factor receptor (EGFR) gene. 
Materials and methods 
Tumor material 
The cell lines Colo320-HSR and HL-60 were both obtained from the 
American Type Culture Collection. Colo320-HSR was derived from a 
colon tumor (Alitalo et aL 1983) and HL-60 from a promyelocytic 
leukemia (Collins and Groudine 1982; Dalla Favera et al. 1982). The 
cell line NCI-H60 was established from a small cell lung cancer (Little 
et al. 1983). Tumor 978/90 wasderived from a male patient with GBM 
according to the World Health Organization (WHO) classification 
(Zfilch 1979). Diagnosis was based on histological examination of 
paraffin-embedded tissue sections and confirmed on tissue that was 
frozen, and finally stained with hematoxylin-eosin. 
Preparation of  tumor DNA 
Cell lines Colo320-HSR and HL60 were propagated in RPMI1640 sup- 
plemented with 10% fetal calf serum. Tissue samples of the glioblas- 
toma tumor 978/90 were frozen in liquid nitrogen immediately after 
surgery and then stored at -80~ Genomic DNA was prepared by stan- 
dard methods (Maniatis et al. 1982) applying proteinase K digestion, 
phenol and chloroforrn/isoamylalcohol (24:1) extraction, and was fi- 
nally precipitated with ethanol. DNA from cell line NCI-H60 was 
kindly provided by J. D. Minna, NIH, Bethesda, Md. 
Cloned probes 
Cosmid cos-myc72 containing an insert of about 30 kb from the c-myc 
gene (MYC) was originally isolated from a cosmid library of the Bur- 
kitt's lymphoma cell line IARC/BL72 (Joos et al. 1992). For detection 
of the EGFR gene (c-erb-1), a c-DNA clone termed pECE-EGFR (3.8- 
kb Sall-Xhol fragment, Haley et al. 1987) was available. This clone 
spans almost the whole transcription unit, except for the last exon. 
In situ hybridization 
Metaphase chromosomes of normal blood lymphocytes (46,XY) were 
prepared according to standard protocols of c lcemid arrest, hypotonic 
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treatment and methanol/acetic acid (3:1) fixation. The protocol used for 
in situ hybridization is described in detail in Lichter and Cremcr (1992). 
DNA was labeled by nick nanslation i  the presence of either diguxi- 
genin-I 1-dUTP or biotin-I 1-dUTP. For a 12-btl hybridization volume, 
0.3-1 [,tg biotinqabeled or digoxigenin-labeled tumor DNA was corn 
bined with 50 gg Cotl fraction of human DNA. When tumor DNA was 
co-hybridized with individual cloned probes, 60 ng digoxigenin-labeled 
cos-myc72 or 200 ng biotin-labeled pECE-EGFR was added to the la- 
beled tumor DNA. Denatured probe was pre-annealed for 15 min at 
37~ and hybridized to denatured chromosomes for 24 h. Following 
post hybridization washes to a final stringency of 0.1 x SSC at 60~ 
hybridized DNA was detected via fluorescein isothiocyanate (FITC)- 
conjugated avidin and anti-digoxigenin rhodamine. Hybridization sig- 
nals of pECE-EGFR were amplified according to Pinkel et al. (1986). 
Chromosomes were counterstained with 4,6-diamino-2-phenyl-indole 
(DAPI). Slides were inspected directly using a conventional epifluores- 
cence microscope and signals were counted to define hybridization effi- 
ciency. An additional analysis was performed using digitized images of 
F1TC, rhodamine or DAP1 fluroescence acquired with a cooled charged- 
couple device (CCD) camera (Photometrics, Tuscon, Ariz.). For docu- 
mentation, images of different fluorochrumes from the same object 
were overlaid electronically following careful realignment using the 
software package Gene Join (Yale University) as described (Ried et al. 
1992). Prior to overlaying, thresholding was applied to images obtained 
from the genomic DNA hybridization in order to show only the peak 
fluorescence. Photographs of digitized images were taken directly from 
the monitor. 
Results 
Detection of amplified 8q24 sequences containing c-myc 
The reverse chromosome painting technique was first applied 
for the detection of amplified sequences by using DNA from 
three tumor cell lines with a known amplification of the 
proto-oncogene c-myc. As listed in Table 1, the c-myc ampli- 
fication unit in Colo320-HSR, HL60 and NCI-H60 differes 
with respect o length and copy number. All tumor DNAs la- 
beled the whole set of normal chromosomes. Above this gen- 
eral staining, highly specific fluorescence signals on 8q24 
were obtained with each of the three tumor DNAs (see Table 
1). One example is presented in Fig. 2A, B. The signal speci- 
ficity was independent of the fluorochrome used for detec- 
tion. Of the evaluated metaphases, 80%-95% showed intense 
fluorescence signals on 8q24 (59%-84% on both homologs). 
Table 1. Length and copy number of c-myc-containing amplification 
units compared with the efficiency of detecting the corresponding re- 
gion by reverse painting 
Cell line Colo320_HSR,~ d NCI_H60d~ HL_60 d 
Copy number 16-32 38 16-24 
Size of amplicon >600 kb >340 kb _>90 kb 
Evaluated metaphases 75 46 44 
Metaphases with signals on 8q24: 
0 signals (%) 5.3 10.9 20.5 
I signal (%) 10.7 13.0 20.5 
2 signals (%) 84.0 76.1 59.0 
Alitalo et al. 1983 
Mengle-Gaw et al. 1987 
Henglein et al. 1989 
d Joos et al. 1992 
~Little et al. 1983 
Kienzler et al. 1986 
In CCD images, a threshold analysis confirmed that the peak 
fluorescence intensities were always observed over band 
8q24. Other signals of corresponding intensity were rarely 
observed and were considered to be background, since they 
did not appear consistently on the same chromosome region. 
Two signals could be seen in most interphase nuclei. 
Co-hybridization experiments were carried out with cos- 
myc72 as a probe to test further whether the signals observed 
after reverse chromosome painting of genomic DNA from 
the three cell lines were generated by amplified sequences 
containing c-myc. These experiments demonstrated that the 
signals from tumor and cosmid DNA were co-localized in all 
metaphase spreads analyzed from the three tumor cell lines. 
One example is shown in Fig. 2B. 
Amp/ification of two genomic regions 
containing proto-onco~enes in a glioblastoma tumor 
To test the potential of reverse chromosome painting for the 
detection of amplified DNA sequences in primary tumor ma- 
terial, we performed an analysis with DNA from a case of 
GBM. Southern blot analysis of this case indicated an ampli- 
fication of the EGFR gene (previous symbol: ERBB; for- 
merly avian erythroblastic leukemia viral (v-erb-b) oncogene 
homolog) located on chromosome 7p13. Reverse chromo- 
some painting using the tumor DNA as probe revealed highly 
intense hybridization signals on 12q 13-q 15 (see Fig. 2C-E). 
In addition, a weaker signal was seen on 7p12-p13, consis- 
tently above the general chromosome staining. Both signals 
could be easily identified by conventional microscopy. Their 
specificity was also confirmed by a threshold analysis of 
CCD images as described above. A total of 32 digitized im- 
ages was analyzed: the chromosome 12 signal was found on 
both homologs in 100% of the metaphase spreads, whereas 
12.5% exhibited the signal on one and 87.5% on both chro- 
mosome 7 homologs. Unexpectedly, the signal on 12q was 
much stronger compared with that on 7p (see Fig. 2C). 
Analysis of elongated chromosomes revealed that it is con> 
posed of two spatially separated signals, a highly intense sig- 
nal on 12q 14-15, and a proximal weaker signal, located most 
probably on 12q13 (see Fig. 2E). Interestingly the two la- 
beled regions 7p13 and 12q13 carry homologous equences 
(see Discussion). 
Using an EGFR c-DNA as a co-hybridization probe, the 
corresponding signal was found to co-localize with the tumor 
DNA signal on 7p (Fig. 2D) in all metaphase spreads ana- 
lyzed (n = 32). In addition, a second, much weaker signal was 
found to co-localize with the major tumor DNA signal on 
band 12q13-q15. This minor signal was seen in 15% of the 
metaphase spreads on both chromosomes 12, and in 37cA on 
one chromosome 12 homolog. Thus, both the tumor DNA 
and the EGFR c-DNA probe generated two signals at the 
same chromosomal sites. However, the major signal obtained 
with the tumor DNA was on 12% whereas the major signal 
obtained with the c-DNA was on 7p. 
Visual inspection of CCD images by several independent 
observers of normal metaphase spreads painted with the 
glioblastoma tumor DNA consistently revealed a weaker 
staining of both chromosomes 10 and the X chromosome 
(Fig. 2C; for details of the evaluation procedure, see du 
Manoir et al. 1993). This observation can be attributed to a 
Fig. 2A-E. Reverse chromosome painting of normal chromosomes with 
a genomic tumor DNA. A-CCD image of a normal human metaphase 
spread, 46(XY), after CISS hybridization with biotin-labeled genomic 
DNA of the tumor cell line HL60. The hybridized probe was detected 
via FITC. Above the general level of chromosome painting, two highly 
intense signals are visible on chromosome 8q24 (arrows). B The same 
metaphase spread after overlaying of three digitized images ach ob- 
tained from a different fluorochrome: (1) DAPI-stained chromosomes 
shown in blue; (2) the FITC image presented in A after a thresholding 
procedure to delineate only the peak fluorescence intensities, and show- 
ing green spots demonstrating the location of the most intense signals 
on 8q24; (3) digoxigenin-labeled probe for c-myc detected via rho- 
damine (rod spots). For illustration purposes, the image of the c-myc 
probe was shifted by two pixels to resolve the green and red signals. C 
Gray level CCD image of a normal metaphase chromosome spread hy- 
bridized with genomic DNA from a glioblastoma (GBM) carrying an 
amplification of the EGFR gene on chromosome 7p13. Digoxigenin-la- 
beled tumor DNA was detected via rhodamine. Specific signals with 
high fluorescent intensity appear on the short arm of chromosome 7 
(7p13) and, even stronger, on the long arm of chromosome 12 
(12q13~115). Note the weak labeling of the X chromosome and both 
chromosome 10 homologs uggesting an under-representation of these 
chromosomes in the tumor. D The same metaphase asin C presented af- 
ter overlaying of three pseudocolored digitized images a described in 
B~ DAPI-banded chromosomes are shown in blue, the rhodamine image 
of C (optimized to show the peak fluorescence) is seen in red. A co-hy- 
bridized EGFR probe, biotin-labeled and detected via FITC, is shown in 
green (arrows). Note the co-localization of the EGFR signal and the tu- 
mor DNA signal on 7pl 3. E Partial prometaphase chromosome spread 
showing the hybridization signals on chromosome 12 obtained with bi- 
otinylated GBM DNA. Note that two signals (arrows) can be detected, a 
proximal weaker signal (most probably on 12q13) and a distal, much 
stronger signal (12q14-q15) 
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loss of chromosome 10 and the hemizygosity of the X chro- 
mosome in the tumor genome derived from a male patient 
(see Discussion). 
Discussion 
In this study, we have demonstrated that amplified sequences 
can be readily detected by in situ hybridization of total ge- 
nomic DNA to normal human chromosomes. The corre- 
sponding signals are immediately visible in the microscope. 
Reverse chromosome painting was carried out using the 
DNA of three tumor cell lines in which the proto-oncogene 
MYC is known to be amplified. The efficiency in visualizing 
chromosomal band 8q24 harboring MYC roughly correlated 
to the amount of sequences over-represented in the probe 
DNA. The cell line Colo-320 containing most of the addi- 
tional sequences (16-32 copies of an amplification unit of 
more than 600 kb) showed the highest efficiency (95%) in 
delineating the corresponding region on one or both ho- 
mologs (see Table 1). The lowest efficiency (80%) was seen 
with cell line HL-60, which contains the smallest amount of 
multiplied DNA (approximately 20 copies of about 90 kb). 
Thus, the sensitivity of the approach is at least in the range of 
detecting a 20-fold multiplication of a fragment approxi- 
mately 100 kb in length. By analogy to gene mapping exper- 
iments, it is expected that signals on 30%40% of the 
metaphases are sufficient o define a specifically labeled re- 
gion. Therefore, the sensitivity defined by HL-60 in this re- 
port is probably an under-estimation of the general sensitivity 
of the approach. It should be noted that the typical ength of 
amplification units described so far is between 200 and 
2000 kb (Ruppert et al. 1991). This range includes the c-myc- 
containing units of the cell lines Colo320-HSR and NCI-H60 
investigated in this study. 
In addition to the highly intense signals on8q24, the fluo- 
rescence along all chromosomes appeared not to be evenly 
distributed. The impact of such a distribution on the diagno- 
sis of gains and losses of chromosomal regions is discussed 
below and analyzed in detail in du Manoir et al. (1992). 
The reverse chromosome painting approach was also used 
to analyze a case of GBM. In this tumor, the recurrent chro- 
mosome aberrations found by karyotype analysis are gains of 
chromosome 7, losses of chromosomes 10 and 22, and gono- 
somes. DMINs are found in 30%-50% of the cases (Sand- 
berg 1990). Amplification of EGFR has been found in 
29%-50% of GBM cases (Fuller and Bigner 1992) and has 
also been detected by Southern blot analysis in the case ana- 
lyzed in this study. This finding could be confirmed by re- 
verse chromosome painting using the tumor DNA; a specific 
signal on band 7p13 co-localized with an EGFR hybridiza- 
tion signal. The additional split signal on the long arm of 
chromosome 12 was unexpected. The weaker signal on 
12q13 could be explained by cross-hybridization f the 
EGFR sequences contained in the tumor DNA to ERBB3, a 
homolog of the EGFR gene family mapping to 12q13. Co- 
amplification of the ERB3 region can be considered as an al- 
ternative explanation. 
The major signal on chromosome 12q14-q15 obtained 
with the GBM tumor DNA was much stronger than the signal 
on 7p13. Since the Southern blot data independently revealed 
an amplification of EGFR, the signal on 7pl 3 cannot be com- 
pletely explained by a cross-hybridization f amplified 12q 
sequences. Thus, co-amplification f sequences in both chro- 
mosomal regions is the most probable xplanation for our 
findings. Notably, numerous genes that are located within 
12q13-q15 have been found to be involved in tumorigenesis 
(Craig and McBride 1991), including the glioma-associated 
oncogene homolog (GLI), a member of the Krtippel family of 
zinc finger protein genes. This gene maps to 12q 13-q14 and 
has been found to be amplified in about 2%-4% of glioblas- 
tomas (Fuller and Bigner 1992). Further proto-oncogenes 
that might be contained in the amplified or co-amplified re- 
gions are the ras homolog RAP1B (12q14), the melanoma- 
associated antigen CD63 gene (12q 12-q 13), the retinoic acid 
receptor gene RAR-gamma (RARG on 12q13), and the int-1 
proto-oncogene (WNT1, former INT1, on 12q13). Thus, the 
results obtained by reverse chromosome painting have 
rapidly provided a series of candidate genes that might be 
amplified and that may possibly play a pathogenetic role in 
this tumor. 
Until now, analysis of the material constituting DMINs re- 
lied on hybridization experiments ofcandidate sequences. As 
a rule, large batteries of proto-oncogene probes were used in 
time-consuming analyses. Furthermore, sequences present in 
DMINs and HSRs could often not be identified, because of 
the limited number of suitable probes. In contrast, the ap- 
proach of reverse chromosome painting gives an immediate 
clue regarding the chromosomal origin of amplified genomic 
sequences. Conventional analyses have often revealed only 
one amplified sequence in DMINs. However, since DMINs 
in tumors can result from co-amplification f sequences from 
different areas of the genome (Alitalo and Schwab 1986), im- 
portant information about amplified DNA might be missed. 
As demonstrated in this study, reverse chromosome painting 
allows us to visualize co-amplified chromosomal regions in a 
single experiment. Furthermore, this approach provides a 
tool for screening large numbers of cases with respect o 
chromosomal regions that are commonly amplified in a par- 
ticular type of tumor, and also for studying the time course of 
amplification events during tumor development. 
In principle, any cellular material from which DNA can be 
extracted can be used for this analysis. Thus, the reverse 
chromosome painting technique is particularly useful for 
cases in which the preparation of chromosome spreads fails, 
as for example in many solid tumors. The potential of the ap- 
proach will be further increased if DNA from tissue sections 
obtained for routine diagnostic applications, uch as paraffin- 
embeded tissues, can be used as a probe. This would also al- 
low the use of archived material for retrospective studies of 
tumor-associated chromosomal mplifications and other ge- 
netic imbalancies. With the advent of techniques for the gen- 
eral amplification of DNA by PCR using universal primers 
(e.g. degenerated oligonucleotide primed (DOP)-PCR, see 
Telenius et al. 1992), it can be expected that even small tissue 
samples will be sufficient as source material. 
Inspection of the signal intensities along chromosomes not 
only revealed stronger signals indicative of amplification, but 
also showed areas of weaker staining. With the GBM DNA, 
chromosomes 10 and X were consistently stained less in- 
tensely than the average painted chromosomes. Loss of chro- 
mosome l0 copies is found in 60% of all GBM cases (Bigner 
and Vogelstein 1990). Thus, the weak labeling of chromo- 
some 10 may indicate monosomy 10 in this tumor case demon- 
strating the detection of  chromosome losses by reverse chro- 
mosome painting. Detai led analysis for accurately assessing 
such chromosomal gains and losses, including gonosomal hy- 
bridization patterns, is presented in du Manoir  et al. (1993). 
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